Lincoln Financial Group and the American Liver Foundation have joined together to raise awareness of hepatitis C in the U.S. and improve educational resources, according to a press release.
“Raising awareness of risk factors and advancements in treatment for hepatitis C is crucial to stemming this silent epidemic, which disproportionately impacts baby boomers,” Tom Nealon, president and CEO of the American Liver Foundation, said in the release. “With continued improvements in detection and treatment, understanding your risk can save your life. The possibility of a cure is well within reach for most people diagnosed with the virus and we encourage everyone to get tested, so they can get treated and get cured.”
The collaboration will focus on raising awareness of the importance of HCV testing for baby boomers and recent medical advancements that can cure HCV.
“With the tremendous strides in curing HCV, the quality of life can be improved in so many ways for those with the disease — from protecting your liver and physical health, to improving mental and emotional health, to overcoming financial planning challenges the disease may have previously presented,” John Greene, MD, vice president and chief medical director at Lincoln Financial Group, said in the release.
In addition to the new collaboration, Lincoln announced that the company has incorporated the newest clinical information about HCV medical advancements in its underwriting approach for life insurance and expanded coverage eligibility for some untreated individuals.
“Lincoln is proud to support the American Liver Foundation to educate and encourage testing, treatment and wellness, and empower those with the disease to take charge of their financial futures by making life insurance more attainable and affordable,” Greene concluded in the release.
Reference: www.lincolnfinancial.com; www.liverfoundation.org